MDGL Annual Operating Profit
-$380.50 M
-$86.92 M-29.61%
31 December 2023
Summary:
As of January 23, 2025, MDGL annual operaing income is -$380.50 million, with the most recent change of -$86.92 million (-29.61%) on December 31, 2023. During the last 3 years, it has fallen by -$173.82 million (-84.11%). MDGL annual operating profit is now -572.43% below its all-time high of $80.54 million, reached on December 31, 2009.MDGL Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MDGL Quarterly Operating Profit
-$116.30 M
+$46.23 M+28.44%
30 September 2024
Summary:
As of January 23, 2025, MDGL quarterly operating income is -$116.30 million, with the most recent change of +$46.23 million (+28.44%) on September 30, 2024. Over the past year, it has increased by +$46.23 million (+28.44%). MDGL quarterly operating profit is now -198.42% below its all-time high of $118.17 million, reached on September 30, 2009.MDGL Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MDGL TTM Operating Profit
-$548.05 M
-$17.77 M-3.35%
30 September 2024
Summary:
As of January 23, 2025, MDGL TTM operating income is -$548.05 million, with the most recent change of -$17.77 million (-3.35%) on September 30, 2024. Over the past year, it has dropped by -$17.77 million (-3.35%). MDGL TTM operating profit is now -686.27% below its all-time high of $93.48 million, reached on March 31, 2010.MDGL TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MDGL Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.6% | +28.4% | -3.4% |
| 3 y3 years | -84.1% | +28.4% | -3.4% |
| 5 y5 years | -835.3% | +28.4% | -3.4% |
MDGL Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -56.9% | at low | -102.0% | +28.4% | -126.0% | at low |
| 5 y | 5-year | -300.6% | at low | -288.3% | +28.4% | -477.1% | at low |
| alltime | all time | -572.4% | at low | -198.4% | +28.4% | -686.3% | at low |
Madrigal Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$116.30 M(-28.4%) | -$548.05 M(+3.4%) |
| June 2024 | - | -$162.54 M(+6.9%) | -$530.28 M(+16.8%) |
| Mar 2024 | - | -$152.04 M(+29.8%) | -$454.20 M(+19.4%) |
| Dec 2023 | -$380.50 M(+29.6%) | -$117.18 M(+18.9%) | -$380.50 M(+9.1%) |
| Sept 2023 | - | -$98.53 M(+14.0%) | -$348.62 M(+5.5%) |
| June 2023 | - | -$86.45 M(+10.4%) | -$330.50 M(+5.1%) |
| Mar 2023 | - | -$78.34 M(-8.2%) | -$314.32 M(+7.1%) |
| Dec 2022 | -$293.57 M(+21.1%) | -$85.30 M(+6.1%) | -$293.57 M(+7.6%) |
| Sept 2022 | - | -$80.41 M(+14.4%) | -$272.87 M(+6.7%) |
| June 2022 | - | -$70.27 M(+22.0%) | -$255.62 M(+3.5%) |
| Mar 2022 | - | -$57.59 M(-10.9%) | -$247.09 M(+1.9%) |
| Dec 2021 | -$242.48 M(+17.3%) | -$64.60 M(+2.3%) | -$242.48 M(+2.1%) |
| Sept 2021 | - | -$63.16 M(+2.3%) | -$237.44 M(+1.9%) |
| June 2021 | - | -$61.74 M(+16.5%) | -$233.06 M(+5.2%) |
| Mar 2021 | - | -$52.98 M(-11.0%) | -$221.65 M(+7.2%) |
| Dec 2020 | -$206.67 M(+117.6%) | -$59.55 M(+1.3%) | -$206.67 M(+16.7%) |
| Sept 2020 | - | -$58.79 M(+16.8%) | -$177.07 M(+24.3%) |
| June 2020 | - | -$50.33 M(+32.4%) | -$142.48 M(+24.0%) |
| Mar 2020 | - | -$38.01 M(+26.9%) | -$114.86 M(+20.9%) |
| Dec 2019 | -$94.97 M(+133.4%) | -$29.95 M(+23.8%) | -$94.97 M(+19.5%) |
| Sept 2019 | - | -$24.20 M(+6.6%) | -$79.47 M(+19.3%) |
| June 2019 | - | -$22.70 M(+25.3%) | -$66.61 M(+28.8%) |
| Mar 2019 | - | -$18.12 M(+25.4%) | -$51.73 M(+27.2%) |
| Dec 2018 | -$40.68 M(+26.9%) | -$14.45 M(+27.5%) | -$40.68 M(+15.8%) |
| Sept 2018 | - | -$11.33 M(+44.8%) | -$35.14 M(+8.3%) |
| June 2018 | - | -$7.83 M(+10.7%) | -$32.44 M(-1.9%) |
| Mar 2018 | - | -$7.07 M(-20.7%) | -$33.06 M(+3.1%) |
| Dec 2017 | -$32.06 M(+27.1%) | -$8.91 M(+3.2%) | -$32.06 M(+3.7%) |
| Sept 2017 | - | -$8.64 M(+2.3%) | -$30.91 M(-15.0%) |
| June 2017 | - | -$8.44 M(+38.9%) | -$36.36 M(+19.0%) |
| Mar 2017 | - | -$6.08 M(-21.7%) | -$30.56 M(+21.2%) |
| Dec 2016 | -$25.22 M(+680.2%) | -$7.75 M(-45.0%) | -$25.22 M(+37.2%) |
| Sept 2016 | - | -$14.09 M(+434.0%) | -$18.39 M(+255.3%) |
| June 2016 | - | -$2.64 M(+257.6%) | -$5.18 M(-76.5%) |
| Mar 2016 | - | -$738.00 K(-19.6%) | -$22.04 M(-47.1%) |
| Dec 2015 | -$3.23 M(-96.1%) | -$918.40 K(+4.4%) | -$41.63 M(-31.3%) |
| Sept 2015 | - | -$880.00 K(-95.5%) | -$60.61 M(-23.5%) |
| June 2015 | - | -$19.50 M(-4.1%) | -$79.18 M(-2.7%) |
| Mar 2015 | - | -$20.33 M(+2.2%) | -$81.38 M(-3.1%) |
| Dec 2014 | -$83.95 M | -$19.89 M(+2.3%) | -$83.95 M(-4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | -$19.45 M(-10.4%) | -$87.50 M(-2.6%) |
| June 2014 | - | -$21.70 M(-5.3%) | -$89.85 M(-0.4%) |
| Mar 2014 | - | -$22.91 M(-2.3%) | -$90.21 M(+3.0%) |
| Dec 2013 | -$87.56 M(+43.7%) | -$23.44 M(+7.6%) | -$87.56 M(+7.0%) |
| Sept 2013 | - | -$21.79 M(-1.2%) | -$81.82 M(+9.7%) |
| June 2013 | - | -$22.06 M(+8.9%) | -$74.56 M(+11.9%) |
| Mar 2013 | - | -$20.26 M(+14.4%) | -$66.63 M(+9.3%) |
| Dec 2012 | -$60.94 M(+34.1%) | -$17.70 M(+21.8%) | -$60.94 M(+14.0%) |
| Sept 2012 | - | -$14.54 M(+2.9%) | -$53.48 M(+4.5%) |
| June 2012 | - | -$14.13 M(-3.0%) | -$51.16 M(+4.3%) |
| Mar 2012 | - | -$14.56 M(+42.3%) | -$49.03 M(+7.9%) |
| Dec 2011 | -$45.43 M(+23.1%) | -$10.24 M(-16.2%) | -$45.43 M(+4.3%) |
| Sept 2011 | - | -$12.22 M(+1.7%) | -$43.56 M(+4.8%) |
| June 2011 | - | -$12.01 M(+9.5%) | -$41.57 M(+7.7%) |
| Mar 2011 | - | -$10.97 M(+31.1%) | -$38.61 M(+4.6%) |
| Dec 2010 | -$36.90 M(-145.8%) | -$8.37 M(-18.2%) | -$36.90 M(+3.9%) |
| Sept 2010 | - | -$10.23 M(+13.1%) | -$35.51 M(-138.2%) |
| June 2010 | - | -$9.04 M(-2.3%) | $92.89 M(-0.6%) |
| Mar 2010 | - | -$9.26 M(+32.6%) | $93.48 M(+16.1%) |
| Dec 2009 | $80.54 M(-185.9%) | -$6.98 M(-105.9%) | $80.54 M(+30.6%) |
| Sept 2009 | - | $118.17 M(-1498.0%) | $61.66 M(-174.3%) |
| June 2009 | - | -$8.45 M(-61.9%) | -$82.97 M(-14.9%) |
| Mar 2009 | - | -$22.20 M(-14.2%) | -$97.46 M(+4.0%) |
| Dec 2008 | -$93.71 M(+41.5%) | -$25.86 M(-2.2%) | -$93.71 M(+11.3%) |
| Sept 2008 | - | -$26.45 M(+15.3%) | -$84.19 M(+15.1%) |
| June 2008 | - | -$22.95 M(+24.4%) | -$73.13 M(+8.1%) |
| Mar 2008 | - | -$18.45 M(+12.9%) | -$67.65 M(+2.2%) |
| Dec 2007 | -$66.22 M(+11.9%) | -$16.34 M(+6.2%) | -$66.22 M(+5.3%) |
| Sept 2007 | - | -$15.39 M(-11.9%) | -$62.88 M(+1.3%) |
| June 2007 | - | -$17.47 M(+2.7%) | -$62.06 M(+39.2%) |
| Mar 2007 | - | -$17.01 M(+30.8%) | -$44.59 M(+61.7%) |
| Dec 2006 | -$59.15 M(-16.9%) | -$13.01 M(-10.8%) | -$27.58 M(+89.2%) |
| Sept 2006 | - | -$14.58 M(-21.2%) | -$14.58 M(-21.2%) |
| Dec 2005 | -$71.18 M(+57.0%) | - | - |
| Mar 2005 | - | -$18.50 M(+239.3%) | -$18.50 M(+239.3%) |
| Dec 2004 | -$45.35 M(+60.3%) | - | - |
| Mar 2004 | - | -$5.45 M | -$5.45 M |
| Dec 2003 | -$28.29 M(+288.0%) | - | - |
| Dec 2002 | -$7.29 M(+1718.5%) | - | - |
| Dec 2001 | -$401.00 K | - | - |
FAQ
- What is Madrigal Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual operating profit year-on-year change?
- What is Madrigal Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly operating profit year-on-year change?
- What is Madrigal Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals TTM operating profit year-on-year change?
What is Madrigal Pharmaceuticals annual operaing income?
The current annual operating profit of MDGL is -$380.50 M
What is the all time high annual operating profit for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual operaing income is $80.54 M
What is Madrigal Pharmaceuticals annual operating profit year-on-year change?
Over the past year, MDGL annual operaing income has changed by -$86.92 M (-29.61%)
What is Madrigal Pharmaceuticals quarterly operating income?
The current quarterly operating profit of MDGL is -$116.30 M
What is the all time high quarterly operating profit for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly operating income is $118.17 M
What is Madrigal Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, MDGL quarterly operating income has changed by +$46.23 M (+28.44%)
What is Madrigal Pharmaceuticals TTM operating income?
The current TTM operating profit of MDGL is -$548.05 M
What is the all time high TTM operating profit for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high TTM operating income is $93.48 M
What is Madrigal Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, MDGL TTM operating income has changed by -$17.77 M (-3.35%)